Jane Street
LSBPW

Jane Street’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Jane Street’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-498,301
Closed -$19.9K – 12005
2025
Q2 		$19.9K Hold
498,301
– – ﹤0.01% 9360
2025
Q1 		$20.5K Hold
498,301
– – ﹤0.01% 9149
2024
Q4 		$39.6K Hold
498,301
– – ﹤0.01% 9028
2024
Q3 		$32.9K Hold
498,301
– – ﹤0.01% 9231
2024
Q2 		$43.9K Hold
498,301
– – ﹤0.01% 8946
2024
Q1 		$35.7K Hold
498,301
– – ﹤0.01% 8813
2023
Q4 		$18.9K Hold
498,301
– – ﹤0.01% 8920
2023
Q3 		$20.5K Hold
498,301
– – ﹤0.01% 8303
2023
Q2 		$23.4K Hold
498,301
– – ﹤0.01% 8343
2023
Q1 		$77.6K Buy
+498,301
New +$75.5K ﹤0.01% 8333

Other funds holding LSBPW

HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Jane Street's LSBPW Position: Q3 2025 in Review

Jane Street sold out of LakeShore Biopharma Warrants (LSBPW) in Q3 2025, closing a stake of 498,301 shares — an estimated $19.9K sold.

Jane Street first reported a position in LSBPW in Q1 2023 and held it in 10 quarters. The position peaked at $77.6K in Q1 2023. 3 funds tracked by Wall St. Rank hold LSBPW as of Q3 2025.

  • Jane Street reported no remaining LakeShore Biopharma Warrants position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 498,301 LakeShore Biopharma Warrants shares in Q3 2025, an estimated $19.9K.
  • Jane Street first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 10 quarters.
  • Jane Street's LakeShore Biopharma Warrants position peaked at $77.6K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.